Editorial
doi: 10.1111/j.1399-3046.2007.00709.x.
Post-transplant metabolic bone complications and optimization of treatment
- PMID: 17493213
- DOI: 10.1111/j.1399-3046.2007.00709.x
Item in Clipboard
Editorial
Post-transplant metabolic bone complications and optimization of treatment
Pediatr Transplant.
2007 Jun.
No abstract available
Comment on
-
The effects of various irradiation doses on the growth and differentiation of marrow-derived human mesenchymal stromal cells.Pediatr Transplant. 2007 Jun;11(4):379-87. doi: 10.1111/j.1399-3046.2006.00663.x. Pediatr Transplant. 2007. PMID: 17493217
Similar articles
-
Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton.J Bone Miner Res. 1996 Jan;11(1):1-7. doi: 10.1002/jbmr.5650110102. J Bone Miner Res. 1996. PMID: 8770690 Review. No abstract available.
-
Orthopedic complications of solid-organ transplantation.Surg Clin North Am. 2006 Oct;86(5):1237-55, viii. doi: 10.1016/j.suc.2006.06.014. Surg Clin North Am. 2006. PMID: 16962412 Review.
-
Metabolic Bone Disease in the Post-transplant Population: Preventative and Therapeutic Measures.Med Clin North Am. 2016 May;100(3):569-86. doi: 10.1016/j.mcna.2016.01.007. Epub 2016 Mar 21. Med Clin North Am. 2016. PMID: 27095646 Review.
-
Metabolic bone disease associated with total parenteral nutrition.Clin Nutr. 2000 Aug;19(4):217-31. doi: 10.1054/clnu.1999.0083. Clin Nutr. 2000. PMID: 10952792 Review. No abstract available.
-
Osteopenia: when you have weak bones, but not osteoporosis. Treatment for low bone density depends on how strong your bones are--not the name of the disease.Harv Health Lett. 2003 Oct;28(12):6. Harv Health Lett. 2003. PMID: 14576026 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
